5th Dec 2019 14:08
(Alliance News) - OptiBiotix Health PLC said on Thursday it has achieved a medical device status and a CE mark for an unflavoured version of SlimBiome Medical.
This provides a product line extension to the existing SlimBiome Medical range which will be launched commercially in the first half of 2020.
Fred Narbel, managing director of OptiBiotix's prebiotics division, commented: "We are very pleased to have been granted a medical device status and a CE mark for the second time over a 12-month period. This line extension will help us convert the commercial opportunities we are working on into distribution agreements."
Shares in OptiBiotix were up 1.2% at 50.60 pence in London on Thursday.
By Lucy Heming; [email protected]
Copyright 2019 Alliance News Limited. All Rights Reserved.
Related Shares:
OptiBiotix Health